Not only for people who work out, but also for those with specific health concerns
it cannot make a high dose appropriate for a low-substrate body, remove the heart-rate tail in a sensitive person, or guarantee anyone reaches 15 mg in real life
The precision medicine era is not coming
Fear of needles, inconvenience, and social stigma all play a role
The standard dose group lost around 10% of their body weight, while the placebo group lost just under 4% of their total body weight
Key Safety Considerations The safety of GLP-1 receptor agonists in older adults is a nuanced question that depends on individual patient characteristics, comorbidities, and careful clinical assessment